These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22319029)

  • 1. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
    Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities.
    Olarescu NC; Ueland T; Godang K; Lindberg-Larsen R; Jørgensen JO; Bollerslev J
    Eur J Endocrinol; 2014 Jan; 170(1):39-48. PubMed ID: 24092547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
    Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of increased visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Cienfuegos JA; Salvador J; Frühbeck G
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):245-53. PubMed ID: 20106640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes.
    Garten A; Petzold S; Barnikol-Oettler A; Körner A; Thasler WE; Kratzsch J; Kiess W; Gebhardt R
    Biochem Biophys Res Commun; 2010 Jan; 391(1):376-81. PubMed ID: 19912992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations.
    Ciresi A; Amato MC; Pizzolanti G; Giordano C
    Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency.
    Miyakawa M; Tsushima T; Murakami H; Isozaki O; Demura H; Tanaka T
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3476-9. PubMed ID: 9768649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.
    Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M
    Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment.
    Olarescu NC; Heck A; Godang K; Ueland T; Bollerslev J
    Neuroendocrinology; 2016; 103(3-4):197-206. PubMed ID: 25592241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women.
    Unlütürk U; Harmanci A; Yildiz BO; Bayraktar M
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):469-74. PubMed ID: 19650786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy.
    Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J
    J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes.
    Ma Y; Cheng Y; Wang J; Cheng H; Zhou S; Li X
    Diabetes Res Clin Pract; 2010 Oct; 90(1):60-5. PubMed ID: 20621376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.
    Pagano C; Pilon C; Olivieri M; Mason P; Fabris R; Serra R; Milan G; Rossato M; Federspil G; Vettor R
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3165-70. PubMed ID: 16720654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.
    Dahl TB; Haukeland JW; Yndestad A; Ranheim T; Gladhaug IP; Damås JK; Haaland T; Løberg EM; Arntsen B; Birkeland K; Bjøro K; Ulven SM; Konopski Z; Nebb HI; Aukrust P; Halvorsen B
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3039-47. PubMed ID: 20392873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.